A Study to Evaluate BMS-986511 in Adults With Major Depressive Disorder
Public ClinicalTrials.gov record NCT07772531. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Monotherapy, Multicenter Study to Evaluate the Efficacy and Safety of BMS-986511 in Two Sequential Parts in Participants With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Study to Evaluate BMS-986511 in Adults with Major Depressive Disorder
Study identification
- NCT ID
- NCT07772531
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 30, 2026 (Estimated)
- Primary completion
- Nov 6, 2028 (Estimated)
- Completion
- Nov 6, 2028 (Estimated)
- Last update posted
- Sep 4, 2026
2026 – 2028
United States locations
- U.S. sites
- 21
- U.S. states
- 12
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0144 | Phoenix | Arizona | 85012 | — |
| Local Institution - 0038 | Little Rock | Arkansas | 72211 | — |
| Local Institution - 0047 | Rogers | Arkansas | 72758 | — |
| Local Institution - 0046 | Garden Grove | California | 92845 | — |
| Local Institution - 0042 | Glendale | California | 91206 | — |
| Local Institution - 0071 | Lemon Grove | California | 91945 | — |
| Local Institution - 0079 | Oakland | California | 94607 | — |
| Local Institution - 0050 | Upland | California | 91786 | — |
| Local Institution - 0007 | Jacksonville | Florida | 32256 | — |
| Local Institution - 0024 | Orlando | Florida | 32801 | — |
| Local Institution - 0140 | Atlanta | Georgia | 30331 | — |
| Local Institution - 0044 | Gaithersburg | Maryland | 20877 | — |
| Local Institution - 0075 | Boston | Massachusetts | 02135 | — |
| Local Institution - 0041 | Cedarhurst | New York | 11516 | — |
| Local Institution - 0069 | Mount Kisco | New York | 10549 | — |
| Local Institution - 0121 | Staten Island | New York | 10312 | — |
| Local Institution - 0083 | Cincinnati | Ohio | 45219 | — |
| Local Institution - 0086 | Columbus | Ohio | 43210 | — |
| Local Institution - 0027 | Oklahoma City | Oklahoma | 73116 | — |
| Local Institution - 0016 | Dallas | Texas | 75231 | — |
| Local Institution - 0003 | Everett | Washington | 98201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07772531, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 4, 2026 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07772531 live on ClinicalTrials.gov.